Key result
A novel homozygous PKP2 variant (c.1511-1G>C) was identified as the probable cause of severe neonatal left ventricular non-compaction and concomitant ventricular septal defect, resulting in death at 11 months.
Why the study?
Severe neonatal LVNC is relatively rare, and homozygous PKP2 mutations have been rarely described.
Case Report (n=1)
A novel homozygous PKP2 variant (c.1511-1G>C) expands the genetic spectrum of PKP2-related disorders to include lethal neonatal left ventricular non-compaction and concomitant ventricular septal defect.
May prompt PKP2 inclusion in neonatal LVNC panels; extends spectrum but leaves clinical utility open.
Left ventricular non-compaction (LVNC) is a rare and genetically heterogeneous cardiomyopathy. The disorder vastly affects infants and young children. Severe neonatal LVNC is relatively rare. The prevalence of genetic defects underlying pediatric and adult-onset LVNC is about 17–40%. Mutations of MYH7 and MYBPC3 sarcomeric genes are found in the vast majority of the positive pediatric cases. PKP2 encodes plakophilin-2, a non-sarcomeric desmosomal protein, which has multiple roles in cardiac myocytes including cell–cell adhesion, tightening gap junction, and transcriptional factor. Most of the reported PKP2 mutations are heterozygous missense and truncating variants, and they are associated with an adult-onset autosomal dominant disorder, namely arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). Homozygous PKP2 mutations have been rarely described. Herein, we present a rare case of an infant with neonatal onset of congestive heart failure owing to severe LVNC and multiple muscular VSD. Medical treatments failed to control the heart failure and the patient died at 11 months of age. Whole-exome sequencing identified a novel homozygous PKP2 variant, c.1511-1G>C, in the patient. An mRNA analysis revealed aberrant transcript lacking exon 7, which was predicted to cause a frameshift and truncated peptide (p.Gly460GlufsTer2). The heterozygous parents had normal cardiac structures and functions as demonstrated by electrocardiogram and echocardiography. Pathogenic variants of sarcomeric genes analyzed were not found in the patient. We conducted a literature review and identified eight families with biallelic PKP2 mutations. We observed that three families (our included) with null variants were linked to lethal phenotypes, while homozygous missense mutations resulted in less severe manifestations: adolescent-onset ARVD/C and childhood-onset DCM. Our data support a previous notion that severe neonatal LVNC might represent a unique entity and had distinct genetic spectrum. In conclusion, the present study has extended the phenotypes and genotypes of PKP2 -related disorders and lethal LVNC.
No takes yet. Share an insight, caveat, or question.
Katanyuwong et al. (2022) conducted a case report in Severe neonatal left ventricular non-compaction and ventricular septal defect (n=1). Homozygous PKP2 variant (c.1511-1G>C) was evaluated on Clinical outcome and genetic diagnosis. A novel homozygous PKP2 variant (c.1511-1G>C) was identified as the probable cause of severe neonatal left ventricular non-compaction and concomitant ventricular septal defect, resulting in death at 11 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: